[Effects and cost-effectiveness analysis of inpatient treatment for XXXX ].

@entity1 @entity308 @entity146 @entity73 @entity2531 @entity7634
@entity1 with @entity2531 represent an expensive problem group of the healthcare system characterized by inappropriately high medical costs. This paper describes a controlled inpatient treatment study using a cognitive-behavioral approach. The aim of this treatment program was to improve the @entity1 ' symptomatology and their psychosocial functioning, as well as reducing unnecessary medical costs. We treated 172 @entity1 with @entity2531 (DSM-IV) and compared them with 262 @entity1 of a waiting control list. An additional control group consisted of 123 @entity1 with other @entity146 . Direct and indirect illness-related costs for the two-year periods before and after treatment were re-calculated using objective data provided by the health insurance companies. The results show a marked improvement in the areas of bodily complaints, health anxieties, dysfunctional beliefs towards body and health, @entity308 and @entity73 . The medical costs in the post-treatment period decreased by 1,098 @entity7634 (-36.7 %) for inpatient and 382 @entity7634 (-24.5 %) for outpatient treatments. Indirect costs due to days lost from work were 6,702 @entity7634 (-35.3 %) lower than during the two-years before treatment. The treatment costs had amortized after 21.5 months. We identified a subgroup of high-utilizing somatoform @entity1 for which per @entity1 savings of 32,174 @entity7634 (-63.9 %) were found. These results confirm that the cognitive-behavioral approach is effective in improving complaints as well as reducing the health-economical @entity2531 .
